MedPath

THE AFFILIATED HOSPITAL OF QINGDAO UNIVERSITY

THE AFFILIATED HOSPITAL OF QINGDAO UNIVERSITY logo
🇨🇳China
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.qduh.cn

Robot-assisted Urological Surgeries Using the MicroHand S Robot

Not Applicable
Recruiting
Conditions
Prostate Cancer
Bladder Cancer
Renal Cancer
Interventions
Device: robot-assisted surgery
First Posted Date
2022-07-18
Last Posted Date
2023-08-02
Lead Sponsor
The Affiliated Hospital of Qingdao University
Target Recruit Count
136
Registration Number
NCT05462392
Locations
🇨🇳

The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

Bioequivalence Study of Eldecalcitol Soft Capsule in Healthy Chinese Subjects

First Posted Date
2022-06-06
Last Posted Date
2022-06-06
Lead Sponsor
The Affiliated Hospital of Qingdao University
Target Recruit Count
58
Registration Number
NCT05406050
Locations
🇨🇳

The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

Observation of the Clinical Efficacy of Two Surgical Procedures for Varus Knee Osteoarthritis

Not Applicable
Completed
Conditions
Knee Osteoarthritis
Interventions
Procedure: CWHTO
Procedure: OWHTO
First Posted Date
2022-05-19
Last Posted Date
2022-05-19
Lead Sponsor
The Affiliated Hospital of Qingdao University
Target Recruit Count
160
Registration Number
NCT05382429
Locations
🇨🇳

Jinli Chen, Qingdao, Shandong, China

Bioequivalence Study of Ezetimibe Tablets Under Fasting Conditions in Healthy Subjects

Phase 1
Conditions
Safety
Pharmacokinetics
Interventions
Behavioral: Reference preparation-Test Preparation
Behavioral: Test Preparation-Reference preparation
First Posted Date
2022-05-19
Last Posted Date
2022-05-19
Lead Sponsor
The Affiliated Hospital of Qingdao University
Target Recruit Count
48
Registration Number
NCT05381870

A Phase I Clinical Study on SHR6390 in Healthy Chinese Volunteers

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
Drug: SHR6390(100mg)
Drug: SHR6390(125mg)
Drug: SHR6390(150mg)
First Posted Date
2022-04-29
Last Posted Date
2022-05-05
Lead Sponsor
The Affiliated Hospital of Qingdao University
Target Recruit Count
36
Registration Number
NCT05354336
Locations
🇨🇳

Phase I Clinical Research Center, Qingdao, Shandong, China

Multimodal Prehabilitation To Improve The Clinical Outcomes Of Frail Elderly Patients With Gastric Cancer

Not Applicable
Active, not recruiting
Conditions
Stomach Neoplasms
Frail Elderly
Interventions
Behavioral: ERAS protocol
Behavioral: Multimodal prehabilitation program
First Posted Date
2022-04-29
Last Posted Date
2024-12-13
Lead Sponsor
The Affiliated Hospital of Qingdao University
Target Recruit Count
368
Registration Number
NCT05352802
Locations
🇨🇳

Department of Gastrointestinal Surgery, Qingdao University Affiliated Hospital, Qingdao, Shandong, China

Intrawound Administration of Vancomycin in TKA

Not Applicable
Completed
Conditions
Knee Osteoarthritis
Interventions
Procedure: Intrawound administration of vancomycin after closure of the arthrotomy
First Posted Date
2022-04-20
Last Posted Date
2023-01-19
Lead Sponsor
The Affiliated Hospital of Qingdao University
Target Recruit Count
100
Registration Number
NCT05338021
Locations
🇨🇳

The affiliated hospital of Qingdao University, Qingdao, Shandong, China

Intrawound Administration of Vancomycin in THA

Not Applicable
Completed
Conditions
Hip
Interventions
Procedure: Intrawound administration of vancomycin after closure of the arthrotomy
First Posted Date
2022-04-20
Last Posted Date
2025-02-04
Lead Sponsor
The Affiliated Hospital of Qingdao University
Target Recruit Count
120
Registration Number
NCT05338008
Locations
🇨🇳

The affiliated hospital of Qingdao University, Qingdao, Shandong, China

Pharmacokinetics and Bioavailability of Curcumin UP 30 Capsules in Healthy Adult Subjects

Phase 1
Conditions
Healthy Adult Subjects
Interventions
First Posted Date
2022-04-19
Last Posted Date
2022-04-19
Lead Sponsor
The Affiliated Hospital of Qingdao University
Target Recruit Count
12
Registration Number
NCT05334043
Locations
🇨🇳

Phase I Clinical Research Center, Qingdao, Shanndong, China

Comparative Study on Tolerance and Pharmacokinetics of Voriconazole for Injection in Healthy Subjects

Phase 1
Completed
Conditions
Healthy Adults
Interventions
Drug: 4 mg/kg Voriconazole
Drug: 6 mg/kg Voriconazole
First Posted Date
2022-04-15
Last Posted Date
2022-04-15
Lead Sponsor
The Affiliated Hospital of Qingdao University
Target Recruit Count
48
Registration Number
NCT05330000
Locations
🇨🇳

Phase I Clinical Research Center, Qingdao, Shanndong, China

© Copyright 2025. All Rights Reserved by MedPath